Homepage

Replimune Group, Inc.

REPL NASDAQ Categories PDF
Healthcare · Biotechnology · United States · Updated May 11, 11:00am
$3.89
Price
$321.2M
Market Cap
479
Employees
0.12
Beta
Sushil Patel
CEO
Business Description

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Business History
Price Overview
Last updated: May 11, 2026 12:45pm (just now)
$3.86
-0.21 (-5.16%)
Day Range
$3.82 – $4.23
52-Week Range
$1.50 – $13.24
50-Day MA
$5.40
200-Day MA
$6.80
Volume
4,605,088.37
Analyst Price Targets
Low $14.00
Consensus $14.00
High $14.00
(15 analysts)
Share Structure
Outstanding 82,572,600.00
Float 76,116,578.00
Free Float 92.2%
High free float — 92.2% of shares trade freely, ~7.8% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-1.27
Stock Price: $3.89
EPS (Diluted): -3.07
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
1.89
Stock Price: $3.89
Total Equity: $415.84M
Shares: 80,564,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-0.87
Market Cap: $321.21M
Total Debt: $46.38M
Cash: $111.12M
EBITDA: -$253.92M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$750.5M
Market Cap: $321.21M
Total Debt: $46.38M
Cash: $111.12M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
0.0%
Operating Income: -$261.63M
Revenue: $0.00
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
0.0%
Net Income: -$247.30M
Revenue: $0.00
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-102.7%
Net Income: -$247.30M
Total Equity: $415.84M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-113.2%
Operating Income: -$261.63M
Tax Rate: -0.2%
Equity: $415.84M
Total Debt: $46.38M
Cash: $111.12M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
7.95
Current Assets: $495.88M
Current Liabilities: $62.36M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.11
Short-Term Debt: $0.00
Long-Term Debt: $46.38M
Total Debt: $46.38M
Total Equity: $415.84M
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 80,564,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$5.16
Total Equity: $415.84M
Shares: 80,564,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-2.47
Operating CF: -$192.25M
CapEx: -$6.69M
Shares: 80,564,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $3.89
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$247.30M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares REPL against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $0 $0
Cost of Revenue $4.1M $4.6M $0 $0 $0
Gross Profit -$4.1M -$4.6M $0 $0 $0
Operating Expenses $78.6M $116.9M $177.1M $234.8M $261.6M
Operating Income -$82.8M -$121.5M -$177.1M -$234.8M -$261.6M
Net Income -$80.9M -$118.0M -$174.3M -$215.8M -$247.3M
EBITDA -$76.5M -$114.4M -$171.7M -$227.8M -$253.9M
EPS $-1.75 $-2.26 $-2.99 $-3.24 $-3.07
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $182.5M $105.9M $146.6M $74.5M $111.1M
Total Current Assets $483.7M $404.0M $592.6M $433.7M $495.9M
Total Assets $543.1M $461.2M $646.6M $487.7M $551.3M
Current Liabilities $14.5M $20.8M $33.8M $40.4M $62.4M
Long-Term Debt $0 $0 $28.6M $44.8M $46.4M
Total Liabilities $44.4M $50.0M $91.3M $113.2M $135.5M
Total Equity $498.7M $411.2M $555.3M $374.5M $415.8M
Retained Earnings -$193.2M -$311.2M -$485.5M -$701.3M -$948.6M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$61.4M -$82.2M -$128.1M -$185.5M -$192.3M
Capital Expenditure -$2.4M -$2.3M -$2.3M -$5.7M -$6.7M
Free Cash Flow -$63.8M -$84.5M -$130.3M -$191.1M -$198.9M
Acquisitions (net) $0 $-530 $140,232 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $123.0M -$76.6M $40.6M -$72.1M $36.7M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $10.7M
$10.7M – $10.7M
 $9.9M
$9.9M – $10.0M
 $120.3M
$120.3M – $120.3M
 $149.2M
$149.2M – $149.2M
EBITDA $0 $0 $0 $0
Net Income -$123.0M
-$165.8M – -$80.2M
 -$77.5M
-$133.1M – -$21.9M
 $205,788
$2,918 – $408,657
 $32.8M
$32.8M – $32.8M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth — — — —
Gross Profit Growth -10.5% +100.0% — —
Operating Income Growth -46.8% -45.8% -32.6% -11.4%
Net Income Growth -46.0% -47.7% -23.8% -14.6%
EBITDA Growth -49.6% -50.1% -32.6% -11.5%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-01 BAKER BROS. ADVISORS LP A-Award 44,500.00 $7.61 $338,645
2026-04-01 Sarchi Christopher A-Award 50,000.00 $0.00 $0
2026-04-01 Sarchi Christopher A-Award 75,000.00 $7.61 $570,750
2026-04-01 Astley-Sparke Philip A-Award 50,000.00 $0.00 $0
2026-04-01 Astley-Sparke Philip A-Award 75,000.00 $7.61 $570,750
2026-04-01 Oliger Christy J. A-Award 44,500.00 $7.61 $338,645
2026-04-01 Xynos Konstantinos A-Award 50,000.00 $0.00 $0
2026-04-01 Xynos Konstantinos A-Award 75,000.00 $7.61 $570,750
2026-04-01 Balachandran Madhavan A-Award 44,500.00 $7.61 $338,645
2026-04-01 Schwendenman Andrew A-Award 36,667.00 $0.00 $0
2026-04-01 Schwendenman Andrew A-Award 55,000.00 $7.61 $418,550
2026-04-01 Patel Sushil A-Award 251,240.00 $0.00 $0
2026-04-01 Patel Sushil A-Award 376,860.00 $7.61 $2.9M
2026-04-01 Dhingra Kapil A-Award 44,500.00 $7.61 $338,645
2026-04-01 Pucci Paolo A-Award 44,500.00 $7.61 $338,645
2026-04-01 SLATTERY JOSEPH P A-Award 44,500.00 $7.61 $338,645
2026-04-01 Peeples-Dyer Veleka A-Award 44,500.00 $7.61 $338,645
2026-04-01 Hill Emily Luisa A-Award 50,000.00 $0.00 $0
2026-04-01 Hill Emily Luisa A-Award 75,000.00 $7.61 $570,750
2026-04-01 Weinand Dieter A-Award 44,500.00 $7.61 $338,645
Community AI Feedback
Sign in to Contribute
No community reviews yet for REPL. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27